EUVIMEDEUVIMED entdecken
Open Access

Metoprolol-spironolactone combination for coronary heart disease with concurrent heart failure: impact on cardiac function

Shujun Zhao, Jiwei Zhang, Yansha Zhao

American Journal of Translational Research · 2026 · 18 (3) · 2247-2255

DOI: 10.62347/oeua7949 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Translational Research, 2026. Verfasst von Shujun Zhao und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, Affiliated Hospital of Hebei University Baoding 071000, Hebei, China. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Metoprololcardiac functioncoronary heart diseaseheart failurespironolactone

Autor:innen und Institutionen

  • Department of Cardiovascular Medicine, Affiliated Hospital of Hebei University Baoding 071000, Hebei, China.

Zitieren

APA

Zhao, S., Zhang, J., & Zhao, Y. (2026). Metoprolol-spironolactone combination for coronary heart disease with concurrent heart failure: impact on cardiac function. American Journal of Translational Research, 18(3), 2247-2255. https://doi.org/10.62347/oeua7949

Vancouver

Zhao S, Zhang J, Zhao Y. Metoprolol-spironolactone combination for coronary heart disease with concurrent heart failure: impact on cardiac function. American Journal of Translational Research. 2026;18(3):2247-2255. doi:10.62347/oeua7949

BibTeX
@article{Zhao2026,
  author = {Zhao, Shujun and Zhang, Jiwei and Zhao, Yansha},
  title = {Metoprolol-spironolactone combination for coronary heart disease with concurrent heart failure: impact on cardiac function},
  journal = {American Journal of Translational Research},
  year = {2026},
  volume = {18},
  number = {3},
  pages = {2247--2255},
  doi = {10.62347/oeua7949}
}
Kostenlos starten →